Offer - Urjas Oil for just ₹ 1
Triglimisave, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Diabetes. Secondary and off-label uses of Triglimisave have also been mentioned below.
The right dosage of Triglimisave depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Triglimisave are Nausea or vomiting, Diarrhoea, Headache. While these are the most often observed Triglimisave side effects, there are can be others also. These have been listed below. Usually, these side effects of Triglimisave go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Triglimisave has a Unknown effect for pregnant women and Safe effect on lactating mothers. Warnings related to Triglimisave's effects on the liver, heart and kidney, if any, have been listed below.
Triglimisave is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Kidney Disease are examples of such conditions.
Drug interactions for Triglimisave have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Triglimisave, it is important to know that it is not safe while driving, and is not habit-forming.
Triglimisave is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Triglimisave safe for pregnant women?
The effects of Triglimisave on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Triglimisave safe during breastfeeding?
Breastfeeding women can safely use Triglimisave.
What is the effect of Triglimisave on the Kidneys?
There can be some harmful effects on your kidneys after taking Triglimisave. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Triglimisave on the Liver?
You may experience side effects on your liver after taking Triglimisave. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Triglimisave on the Heart?
Triglimisave may have mild side effects on the heart. Most people will never see any effect on the heart.
Triglimisave should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Triglimisave unless your doctor advises you to do so -
Is this Triglimisave habit forming or addictive?
Forming a habit of Triglimisave has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Triglimisave can make you feel drowsy.
Is it safe?
Yes, but consume Triglimisave only on doctor's advice.
Is it able to treat mental disorders?
Triglimisave is unable to treat or cure mental disorders.
Interaction between Food and Triglimisave
Due to a lack of research, nothing can be said about the consequences of taking Triglimisave together with food.
Interaction between Alcohol and Triglimisave
It is difficult to say anything about the effect of Triglimisave and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033